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Abstract 
Fragile X syndrome (FXS) is caused by inactivation of the FMR1 gene and loss of encoded 
FMRP, an RNA binding protein that represses translation of some of its target transcripts. Here 
we use ribosome profiling and RNA-seq to investigate the dysregulation of translation in the 
mouse brain cortex. We find that most changes in ribosome occupancy on hundreds of mRNAs 
are largely driven by dysregulation in transcript abundance. Many downregulated mRNAs, 
which are mostly responsible for neuronal and synaptic functions, are highly enriched for FMRP 
binding targets. RNA metabolic labeling demonstrates that in FMRP-deficient cortical neurons, 
mRNA downregulation is caused by elevated degradation, and is correlated with codon 
optimality. Moreover, FMRP preferentially binds mRNAs with optimal codons, suggesting that it 
stabilizes such transcripts through direct interactions via the translational machinery. Finally, we 
show that the paradigm of genetic rescue of FXS-like phenotypes in FMRP-deficient mice by 
deletion of the Cpeb1 gene is mediated by restoration of steady state RNA levels and 
consequent rebalancing of translational homeostasis. Our data establish an essential role of 
FMRP in codon optimality-dependent mRNA stability as an important factor in FXS. 
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Introduction 
Fragile X syndrome (FXS) is the most common form of inherited intellectual disability caused by 
a single gene mutation (1). FXS is caused by a trinucleotide repeat expansion in the FMR1 
locus, which results in transcriptional silencing and loss of its protein product FMRP (2). In 
FMRP-deficient mice, protein synthesis in the brain is elevated by ~15-20% (3, 4), indicating 
that FMRP represses translation. In the mouse brain, FMRP binds mostly to coding regions of 
approximately 850 to 1000 mRNAs (5–9), and co-sediments with polyribosomes (5). FMRP has 
been proposed to repress translation by impeding ribosome translocation (5, 10–13). This 
hypothesis is based on the evidence that ribosomes associated with many of these mRNAs are 
resistant to puromycin treatment in vitro, which causes premature polypeptide release and thus 
is an indirect measure of ribosome translocation, and that ribosomes transit at faster rates in 
FMRP knockout (KO) brain extracts compared to WT (5, 10), FMRP also regulates translation 
directly or indirectly at the level of initiation (14, 15), RNA splicing (13), editing (16, 17), nuclear 
export (18, 19), and m6A modifications (18–20). However, the relationship of these molecular 
impairments to the etiology of Fragile X Syndrome, if any, is unknown.  
Translation is also controlled by the supply and demand of available tRNAs (21). When 
particular codons represented in mRNA are not met by a sufficient supply of charged tRNA, 
ribosome transit slows or stalls, which in turn causes RNA destruction (22–27). Control of 
specific translation and RNA destruction by codon bias varies with tissue (24), time of 
development (23), and cell stress (28). Additionally, in yeast, trans-acting factors can influence 
codon bias-mediated RNA destruction (22), indicating a more complex regulation than simple 
codon-tRNA balance.  
Here, we have used ribosome profiling and RNA-seq to investigate translational dysregulation in 
the FMRP KO cortex and found that FMRP coordinates the link between RNA destruction and 
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codon usage bias (codon optimality). We find that the apparent dysregulation of translational 
activity (i.e., ribosome occupancy) in FMRP KO cortex can be accounted for by commensurate 
changes in steady state RNA levels. Downregulated mRNAs in FMRP KO cortex are enriched 
for those that encode factors involved in neuronal and synaptic functions, and are highly 
enriched for FMRP binding targets. These observations suggest that in the cortex, FMRP 
directly or indirectly regulates RNA stability. Indeed, RNA metabolic profiling by 5-ethynyl uridine 
incorporation and whole transcriptome sequencing reveals wide-spread RNA degradation in 
Fmr1 KO cortical neurons while synthesis and processing rates remained substantially 
unchanged. Of the ~700 mRNAs that degraded significantly faster in FMRP KO cortex 
compared to WT, those enriched for optimal codons were particularly affected. This widespread 
codon-dependent RNA destruction in FMRP-deficient neurons involves a massive reshuffling of 
the identities of stabilizing or destabilizing codons. Moreover, FMRP can distinguish between 
optimal and non-optimal codon-containing mRNAs, probably through the associated 
translational machinery. Finally, we demonstrate that in a genetic rescue paradigm of FXS 
where a double deficiency of FMRP and CPEB1 mitigates the disorder in mice, restoration of 
RNA levels drives the recovery of ribosome occupancy. These results indicate that a primary 
consequence of FMRP depletion from the brain is the uncoupling of codon bias from the RNA 
destruction machinery. This uncoupling may be a general mechanism that underlies FXS, and 
restoration of the RNA stability landscape could be a key to ameliorating the disorder. 
Results 
Steady state RNA level changes drive translational buffering in Fragile X brain cortex 
To identify mRNAs that are translationally dys-regulated in FMRP-deficient mouse cortex, we 
performed ribosome profiling (29) and RNA-seq from WT and Fmr1 KO (FK) animals (Fig 1a). 
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Ribosome occupancy (RO), defined as ribosome protected fragments (RPFs) normalized to 
mRNA levels, is a measure of translational activity (29) and has served as a proxy for protein 
synthesis. Accumulating evidence suggests that one mechanism whereby FMRP inhibits 
translation is by stalling ribosome transit (5, 10, 12, 13) and indeed there is a moderately (10-
15%) higher rate of protein synthesis in FMRP-deficient brain (3, 4, 30). Using Xtail (31), an 
algorithm that tests for differential ribosome occupancies (DROs) between samples, we 
identified 431 mRNAs with DROs between FK and WT (FDR < 0.05; Fig 1b, Fig S1a). 
Consistent with FMRP acting as a translation repressor, 80% of these mRNAs (345/431) have 
increased RO.  
To determine the underlying cause of DRO, we analyzed our RPF and RNA-seq data separately. 
DRO can result from translational dysregulation driven by differential RPF but with little change 
in RNA levels; conversely, translational buffering occurs when RPFs are unchanged but the 
DRO is driven by dysregulated RNA levels (32). The RPF changes in the DRO mRNAs are 
subtle, however, the changes in RNA levels strongly oppose the changes in RO (Fig 1b). When 
taken as a group, these mRNAs with altered ROs have stronger changes at RNA levels than at 
RPF levels (Fig S1a).  
We identified 12 and 21 mRNAs with strongest increase and decrease at RPF level, and 12 and 
93 mRNAs with strongest increase and decrease at steady state RNA level (including Fmr1 
mRNA) (see Material and Methods). The 345 RNAs with increased RO in FK are significantly 
enriched for those with increased RPFs (n = 7, p-value = 4.17 x 10-11, hypergeometric test), but 
much more so for mRNAs with reduced steady state levels (n = 75, p-value = 5.89 x 10-110, 
hypergeometric test). This is also the case for mRNAs with decreased RO (Fig 1c). These data 
show that mRNA steady state level changes drive the observed RO changes, likely via 
translational buffering in the FK brain cortex. 
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Some of the top mRNAs downregulated at the steady state level include those that are involved 
in ion channel function (e.g. Pdzd2 (33) and Wnk2 (34)) and synapse development and 
communication (e.g. Bai2 (35) and Sipa1l3 (36)). Gene Ontology (GO) analysis of 
downregulated mRNAs show an enrichment for functions related to neuronal dendrites, pre- and 
post-synapses, and channels and receptors (Fig 1d; Table S1). The loss of these RNAs could 
contribute to the neurological defects related to FXS. The FMRP binding target RNAs in the 
brain are also highly enriched for these similar GO terms (5). Indeed, over two-thirds of the 
downregulated mRNAs (58/93) are FMRP targets (5) (Fig 1e, enrichment p-val = 7.53 x 10-51, 
hypergeometric test), including the four example genes mentioned above. As a group, the 
FMRP target RNAs are significantly reduced (mean log2FC = -0.12, p-val < 2.2 x 10-16, one-tail t 
test). This observation indicates that the increased RO is caused by reduced RNA levels (mean 
log2FC = 0.17, p-val < 2.2 x 10-16, one tail t test), although their changes at RPF level is very 
subtle (mean log2FC = 0.0093, p-val = 0.00292, one-tail t test) (Fig 1e). These data show that 
in the FMRP-deficient mouse brain cortex, translational buffering is driven by steady state 
mRNA changes, particularly the downregulation of the FMRP target mRNAs. Interestingly, the 
downregulation of mRNAs, including FMRP binding targets, is observed across multiple FXS 
mouse and human models (Fig S1), suggesting that reduction of these mRNAs could underlie 
FXS. 
RNA metabolic profiling reveals disrupted RNA stability in FMRP-deficient neurons 
Because FMRP is mostly a cytoplasmic protein (11), we hypothesized that the downregulation 
of its target (and other mRNAs) is due to a post-transcriptional mechanism, possibly 
destabilization upon loss of FMRP. To test this hypothesis, we incubated WT and FK mouse 
cortical neurons (14 DIV) with 5-ethynyl uridine (5EU) for 0 (i.e., unlabeled control, or “unlab”), 
20 (library A), or 60 min (library B), after which the RNA was “clicked” to biotin and purified by 
streptavidin chromatography. The RNA was mixed with 5EU-labeled Drosophila RNA and 
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unlabeled yeast RNA as controls and sequenced together with total unenriched RNAs as input 
samples (Fig 2a). The spike-in Drosophila and yeast RNAs for library generation were used as 
quality control measures, showing that the WT and FK libraries were of equal quality (Fig S2a-
c). After filtering (Fig S2d), we calculated RNA metabolism rates (synthesis, processing, and 
degradation) by comparing nascent and mature RNA concentrations in the 5EU-labeled and 
input total RNA libraries using the INSPEcT algorithm (37, 38). We obtained metabolism rate 
information for 8590 RNAs, which include 412 FMRP target mRNAs. The rates follow log-
normal distributions with medians of 1.12 and 1.04 RPKM/hr for synthesis, 6.84 and 6.60 hr-1 for 
processing, and 0.13 and 0.14 hr-1 for degradation for libraries A and B, respectively (Fig S2e). 
These values demonstrate the reproducibility of the assay. 
We calculated Spearman’s correlation coefficients for all three metabolism rates for the two 
genotypes for both libraries (Fig 2b). For synthesis, processing, and degradation, we observed 
decreasing correlation coefficients between WT and FK. For synthesis rates, WT and FK cluster 
together for the same labeling parameter (library A or B), indicating that there is little genotype 
difference. For libraries A and B, the correlation coefficients were 0.97 and 0.88 between WT 
and FK, again demonstrating that the synthesis rates between the two genotypes are similar. 
For processing rates, the two genotypes were also similar despite slightly lower Spearman’s 
correlation coefficients between WT and FK (0.79 and 0.61 for libraries A and B). Strikingly, the 
correlation coefficients for degradation rates between WT and FK were substantially lower (0.22 
and 0.36 for libraries A and B), indicating that there is a major difference in RNA degradation 
between genotypes. The Spearman’s correlation coefficients between libraries A and B for each 
genotype (0.87 and 0.72, respectively) indicate high reproducibility. Therefore, the degradation 
rates for the four libraries are separated by genotype (Fig 2b), demonstrating that RNA stability 
in FK neurons is disrupted. 
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We determined whether the following groups of mRNAs have altered degradation rates: 1) 
mRNAs that are downregulated (Fig 2c), 2) FMRP targets (Fig 2d), and 3) mRNAs that have 
DROs (Fig 2e). For convenience, we will refer to group 1 as downregulated mRNAs and group 
3 as RO up/down mRNAs, respectively. Statistical tests were performed on log10 transformed 
degradation rates. In WT neurons, the downregulated mRNAs degraded significantly slower 
than the other RNAs (p-val = 1.31 x 10-6, two-tailed t test). However in FK neurons, the 
downregulated mRNAs degraded significantly faster (p-val = 0.000684, two-tailed t test) (Fig 2c, 
left). Moreover, the mRNAs in FK neurons are globally destabilized relative to those in WT 
neurons (for the mRNAs not downregulated in FK cortex, the difference of log10 degradation 
rate means in FK vs WT = 0.17 1/hr, p-value < 2.2 x 10-16, two-tailed t test), however the 
downregulated mRNAs are destabilized even more (difference of log10 degradation rate means 
in FK vs WT = 0.53 1/hr, p-value = 2.09 x 10-15, two-tailed t test) (Fig 2c, right). FMRP targets 
and RO up mRNAs are also destabilized more than the global trend (Fig 2d, e). Interestingly, 
the RO down mRNAs were resistant to mRNA destabilization upon loss of FMRP; their 
degradation rates are not significantly different in FK compared to WT neurons (p-val = 0.323, 
two-tailed t test) (Fig 2e, right). This resistance to transcriptome-wide destabilization could 
explain the observed steady state upregulation of these mRNAs (Fig 1b).  
We did not identify RNAs with dysregulated synthesis or processing rates in FMRP-deficient 
neurons, but detected 748 RNAs with altered degradation rates, of which 688 (92%) degraded 
faster in FK compared to WT (adjusted p-value cut-off of 0.01) (Fig 2f). The RNAs that 
degraded faster in FK neurons were significantly enriched for FMRP targets as well as those 
that were downregulated at the steady state level in the cortex (Fig S2g). As groups, the RNAs 
that degraded faster or slower in FK neurons displayed decreased or increased steady state 
levels (p-val = 5.49 x 10-14 and 1.47 x 10-4, two-tailed t test), as well as increased or decreased 
ROs in FK cortex, respectively (p-val < 2.2 x 10-16 and = 5.28 x 10-3), with no change at the RPF 
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level (Fig 2g). Based on these data, we conclude that there is widespread mRNA destabilization, 
including many of the FMRP targets, in the absence of FMRP; this in turn drives steady state 
RNA level changes and translation buffering. 
Loss of FMRP uncouples the link between optimal codons and mRNA stability 
To identify features of mRNAs that are involved in this FMRP-dependent stability, we examined 
the correlation of brain cortex steady state mRNA level changes or neuronal mRNA degradation 
rate changes with codon optimality (gene codon Adaptation Index (cAI) score , see Material 
and Methods), coding sequence (CDS) guanine-cytosine (GC) content, CDS, 5’ and 3’ 
untranslated region (UTR) lengths and their minimal energy of folding (MEF, an indication of 
possible secondary structure) (Fig S3a). The strongest and most consistent correlations with 
both cortical steady state mRNA level changes and neuronal mRNA degradation rate changes 
were gene cAI scores and CDS GC content, which are correlated features themselves (39, 40). 
More specifically, the log2FC of cortical steady state mRNA levels had a negative correlation 
with gene cAI scores (Spearman’s correlation coefficient = -0.22, p-value < 2.2 x 10-16) while the 
log2FC of the neuronal mRNA degradation rate had a positive correlation (Spearman’s 
correlation coefficient = 0.20, p-value < 2.2 x 10-16) (Fig S3a). This means mRNAs which 
contain more optimal codons were the ones that had faster degradation rates and showed a 
consequent downregulation in FK. 
Codon optimality, a measure of the balance between the usage frequency of a given codon 
(demand) and supply of charged tRNAs encoding the complementary anticodon (21), is a major 
determinant of mRNA stability from yeast to vertebrates (22–27). Generally, mRNAs with more 
optimal codons (high gene cAI scores; presumably with faster decoding rates) are more stable 
than mRNAs using less optimal codons, connecting translation regulation to mRNA stability. 
Because FMRP regulates translation, codon optimality could be a mechanism that links FMRP-
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mediated translation to mRNA stability. Therefore, we investigated the role of codon optimality 
in FMRP-dependent mRNA stability. 
We grouped all detectable mRNAs into 10 equal sized bins of increasing gene cAI score and 
examined which bins were particularly affected by mRNA degradation rates (Fig 3a). mRNAs in 
bins 4-10 degraded significantly faster in FK neurons than in WT neurons (Holm adjusted p-
value < 0.01, one tailed-t test); the higher the cAI score bin, the faster the rate of degradation. 
However, mRNAs in bins 1-3 were barely changed, indicating that mRNAs containing non-
optimal codons are resistant to destabilization upon loss of FMRP. 
Compared to the general transcriptome (gene cAI scores = 0.78 ± 0.038, mean ± standard 
deviation), mRNAs that degrade faster in FK neurons (gene cAI scores = 0.79 ± 0.033) and the 
mRNAs that are downregulated in the cortex (gene cAI scores = 0.80 ± 0.023) have significantly 
more optimal codons (p-val < 2.2 x 10-16 and 1.12 x 10-14, two-tailed t test). However, the 
mRNAs that degrade slower in FK neurons (gene cAI scores = 0.76 ± 0.034) are significantly 
less optimal (p-val = 2.85 x 10-4, two-tailed t test) (Fig 3b). These results indicate that FMRP 
stabilizes mRNAs that have an optimal codon bias. 
Because optimal codons may confer stability to mRNAs (22–27), we examined whether this link 
is uncoupled upon loss of FMRP. The codon-stability coefficient (CSC), which describes the link 
between mRNA stability and codon occurrence, has been calculated for each codon from yeast 
to human (23, 24, 26, 27). We determined whether this relationship is maintained in the 
absence of FMRP. The CSC values in WT neurons ranged from < -0.2 to > 0.2, which is 
comparable to previously reported CSC values for human cell lines and mouse embryonic stem 
cells (Fig S3b). This differs from what has been described in Drosophila where the neuronal 
CSC is attenuated relative to somatic cells (24). Of the 60 non-start or -stop codons, 29 had 
CSCs greater than 0 (stabilizing codons) and 31 had CSCs smaller than 0 (destabilizing 
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codons) (Fig 3c, upper). Strikingly, 17 codons that are stabilizing in WT are destabilizing in FK 
neurons, and 21 codons changed in the opposite direction (Fig 3c, lower). Optimal codons are 
prevalent in abundant mRNAs and are associated with positive CSCs (i.e., are stabilizing 
codons) (23, 24, 26, 27), as we have observed in WT neurons (Fig 3d upper) (Spearman’s r = 
0.55, p-value = 1.92 x 10-5). In FK neurons, however, this relationship breaks down. Codon 
usage frequencies in the top 10% of highly expressed mRNAs are the same as in WT (data not 
shown), but the correlation between codon usage frequencies and CSCs is nearly random in FK 
(r = 0.067, p-value = 0.612) (Fig 3d). These results show that the link between codon-mediated 
RNA stabilization and codon usage bias is uncoupled in FMRP-deficient neurons. 
FMRP may stabilize codon optimality dependent mRNA stability directly and through 
other factors 
We considered possible mechanisms for how FMRP could regulate codon optimality-dependent 
mRNA stability. Because the downregulated mRNAs are enriched for FMRP targets, FMRP may 
stabilize them through direct binding. We noticed a bias for high gene cAI scores of the FMRP 
targets (Fig 4a) and hypothesized that FMRP may associate with mRNAs of higher codon 
optimality. To test this, we compared a pair of previously described reporter mRNAs that are 
enriched in optimal or non-optimal codons (27). They differ by a single nucleotide insertion to 
induce a frame-shift, and thus they have almost identical nucleotide compositions. HEK293T 
cells were transduced with these reporters together with a FLAG-tagged FMRP-expressing 
vector (41). Subsequent anti-FLAG immunoprecipitation and RT-qPCR showed that the reporter 
with optimal codons was more enriched compared to the reporter with non-optimal codons (p-
value = 0.0261, one-tailed paired t test; Fig 4b). This result suggests that FMRP can indeed 
“identify” mRNAs with optimal codons as opposed to general nucleotide composition.  
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We next examined whether FMRP binding could impact RNA stability. As a group, the 
degradation rate of FMRP CLIP targets was higher than the non-target RNAs (p-value = 1.36 x 
10-9, one-tailed t test; Fig S4a). Because too few FMRP targets (30%) were detected in the 
degradation rate data set, we focused on the steady state RNA changes and compared RNAs in 
each cAI score bin. Similar to the global trend discussed above (Fig 3a), FMRP targets with 
more optimal codons were also more strongly downregulated than those with non-optimal 
codons (Spearman’s correlation coefficient of RNA log2FC and gene cAI score bin = -0.21, p-
value = 8.27 x 10-8). However, FMRP targets in all but the lowest codon optimality bin were 
significantly reduced in the absence of FMRP (Holm adjusted p-value < 0.01, one-tailed t test) 
(Fig 4c, red). This is different from the codon optimality matched non-targets (Fig 4c, black). 
The non-target mRNAs also showed an optimal codon biased downregulation (Spearman’s 
correlation coefficient of RNA log2FC and gene cAI score bin = -0.20, p-value < 2.2 x 10-16), but 
only RNAs in cAI bins 7, 8, and 9 are significantly downregulated (Holm adjusted p-value < 0.01, 
one-tailed t test). In all gene cAI score bins, the log2FC of the FMRP targets are significantly 
more negative than the non-target RNAs (Holm adjusted p-value < 0.01, one-tailed t test). 
These results suggest that the stability of the FMRP target RNAs is not only affected by their 
codon optimality, but also by the FMRP binding. 
Not all mRNAs that are depleted in the FK cortex are FMRP CLIP targets, suggesting that 
FMRP could also stabilize mRNAs through other factors. For example, YTHDF2 was shown to 
antagonize FMRP’s stabilizing effect for some of FMRP targets in mouse brain cortex (20), and 
knockdown of this protein in human cell lines (42) leads to longer half-lives of the FMRP targets 
(D = 0.14, p-value = 2.19 x 10-7, two-sided KS test) and of mRNAs downregulated in the FK 
cortex (D = 0.37, p-value = 3.56 x 10-5, two-sided KS test) (Fig 4d).  
We examined RNA-seq datasets to assess other factors that might be involved in FMRP-
mediated optimal codon-dependent mRNA stability. We selected factors that target mRNAs of 
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higher GC content (43) or higher codon optimality (44), and therefore the RNA level changes 
upon depletion of these factors likely affects their stability (Fig 4d, Fig S4b). Depletion of XRN1 
(5’−3’ exonuclease)  and DDX6 (DEAD-Box Helicase 6) in human cell lines (43) leads to 
upregulation of the mRNAs downregulated in FK cortex (D = 0.42, p-value = 4.05 x 10-8; D = 
0.37, p-value = 2.24 x 10-6, two-sided KS test) (Fig 4d). On the other hand, depletion of FXR1 
(Fragile X Mental Retardation Syndrome-Related Protein 1) (45) leads to downregulation of the 
orthologs of FMRP targets (Fig S4b). These results suggest that XRN1 and DDX6 might 
antagonize FMRP while FXR1 might cooperate with it to stabilize mRNAs of high codon 
optimality.  
CPEB1 depletion rescues FXS by rebalancing RNA homeostasis 
Nearly all pathophysiologies associated with FMRP deficiency are rescued in FMRP/CPEB1 
double knockout (dKO) mice (10). To assess how this rescue could be achieved, we performed 
ribosome profiling and RNA-seq on CPEB1 KO (CK) and dKO mouse brain cortices in addition 
to the WT and FK samples as described above (Fig 5a). We identified 651 genes with DROs 
among the four genotypes (FDR < 0.05; Fig 5b), including the 431 genes with DRO between FK 
and WT described above (Fig 1b). Importantly, 425 of these DROs were rescued in the dKO 
cortex (i.e., not significantly different compared to WT). Unexpectedly, >50% of RNAs with DRO 
in CK (204 out of 359) also had DROs in FK, and were changed in the same direction (i.e., 
increased or decreased). These molecular data are consistent with previous observations such 
as dendritic spine number and metabotropic glutamate receptor-mediated long term depression 
(mGLurRLTD), which are nearly identically aberrant in the two single KO mice but rescued to 
normal in dKO animals (10). Because of the molecular similarities between WT and dKO, and 
between FK and CK, we henceforth refer to these two groups as “normal” and “FXS-like.” 
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To determine the underlying molecular driver of the DRO among the four genotypes, we 
analyzed our RPF and RNA-seq data separately. At padj < 0.05, only 23 and 21 RPFs were 
significantly different between FK and WT and between CK and WT. Conversely, the dKO was 
the most different from WT with 410 and 333 RPFs that were significantly higher or lower (Fig 
5c). Therefore, this genetic rescue of FXS-like phenotypes in the dKO is not achieved by 
correcting translational activity as defined by the number of RPFs. In contrast, the RNA-seq 
heatmap displayed a mirror image of the DRO heatmap (Fig S5a). Compared to WT, the 
expression of 50 genes was dys-regulated in FK (padj < 0.05; 10 up-regulated, 40 down-
regulated), 145 in CK (padj < 0.05; 13 upregulated, 132 downregulated), but only 2 in dKO (padj 
< 0.05; Cpeb1 and Fmr1). The differentially expressed (DE) genes in FK and CK were largely 
identical. Among the 10 and 13 genes up-regulated in FK and CK, 7 overlap (p = 8.72 x 10-25, 
hypergeometric test, upper tail); among the 40 and 132 genes down-regulated, 35 overlap (p = 
3.91 x 10-72, hypergeometric test, upper tail). Because the transcriptome profiles in FK and CK 
are as similar as the WT and dKO profiles, we performed an unsupervised hierarchical 
clustering to test for sample to sample similarities (Fig S5b). FK and CK formed one cluster 
while WT and dKO formed another, validating the “FXS-like” vs “normal” grouping at the RNA 
level. 
Having validated the grouping, we tested for DE RNAs in the FXS-like group (FK and CK) 
relative to the normal group (WT and dKO). The DE RNAs between the groups are changed the 
same direction (i.e., up or down) in the single KOs and are rescued in the dKO to WT levels. 
With greater statistical power than when comparing between single genotypes, we identified 
733 dys-regulated RNAs in the FXS-like group (padj < 0.01), 162 (22.1%) up-regulated and 571 
(77.9%) down-regulated (Fig 5d). Almost all downregulated RNAs in FK compared to WT are 
downregulated in the FK-like group (87/93). Over 77% of the RNAs with up-regulated ROs in FK 
vs WT (267 out of 345) were significantly reduced in the FXS-like group (p-value = 0, 
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hypergeometric test, upper tail). Similarly, 42% of the RNAs with down-regulated ROs in FK (36 
out of 86) were significantly increased steady state levels (p-value = 3.28 x 10-51, 
hypergeometric test, upper tail). Therefore, we conclude that rescue of FXS in FMRP/CPEB1 
dKO animals is achieved by rebalancing the transcriptome.  
Discussion 
It is widely assumed that excessive protein synthesis is not only a corollary of FXS, but a 
proximate cause of the disorder (46). Consequently, several studies have used high resolution 
whole-transcriptome methods to identify mRNAs that are either bound by FMRP (5–9) or whose 
translation is dysregulated in FMRP-deficient mouse models (5, 12, 13, 47, 48). Although nearly 
1000 FMRP binding targets have been identified in the mouse brain, surprisingly few are 
dysregulated at the translational level, and of those that are, the dysregulation is usually 
modest. Moreover, in even fewer cases has the dysregulation been linked to FXS 
pathophysiology (49). Therefore, the functional output of FMRP binding remains largely elusive. 
Our study shows that in the FK mouse brain cortex, steady state mRNA levels are globally 
disrupted, which drive the dysregulated translational buffering (Fig 1, 5). FMRP targets are 
particularly downregulated, which happens specifically in neurons (50). By metabolic labeling 
and RNA-seq in neurons, we show that the loss of FMRP results in reduced stability not only of 
its direct target substrates, but also of other mRNAs with an optimal codon bias (Fig 2, 3). This 
instability drives the changes in steady state RNA levels and translational buffering in the cortex 
(Fig 2). Moreover, our data demonstrate that RNA stability conferred by optimal codons is 
mediated by FMRP and possibly other trans-acting factors. The loss of FMRP leads to a 
massive reshuffling of the identities of stabilizing versus destabilizing codons (Fig 3).  
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Rebalancing of RNA levels is accompanied by and probably necessary for mitigation of FXS-like 
phenotypes in mice by CPEB1 depletion (Fig 5) (10). Among the mRNAs dysregulated between 
the FXS-like group (i.e., FK and CK) and the normal group (WT and FK/CK dKO), GO analysis 
shows that many up-regulated and rescued mRNAs have protein synthetic functions including 
ribosome biogenesis, translation, and protein folding, while the down-regulated and rescued 
mRNAs have cell projection, synaptic transmission, as well as transcription and chromatin 
functions (Fig S6a; Tables S2-3). Several important points come from this analysis. First, the 
up-regulated mRNAs are among the highest expressed in the brain (Fig S6b), and their protein 
products could promote general protein synthesis. This could explain the net increase in protein 
output in the FXS brain (3, 4, 30). Second, we find that FMRP regulates the levels of mRNAs 
that encode chromatin modifying factors, which is reminiscent of other observations showing 
that FMRP controls the synthesis of epigenetic regulators, albeit at the translational level (13, 
49). Third, the brain and neuron related GO terms enriched for the down-regulated RNAs reflect 
the neural dysfunction that occurs in FXS. Indeed, the down-regulated RNAs are also 
significantly enriched for those related to autism as compiled by the Simons Foundation SFARI 
project (51) (Fig S6c; p = 3.56 x 10-7, hypergeometric test, upper tail). Therefore, restoring RNA 
homeostasis could be a key to FXS treatment. 
How does FMRP stabilize mRNAs that use optimal codons? One possibility is that FMRP can 
stabilize its targets by directly interacting with the translational machinery. We show that FMRP 
preferentially binds an mRNA reporter that contains optimal codons over a reporter that contains 
non-optimal codons but has nearly the same nucleotide composition (Fig 4b). Upon loss of 
FMRP, target mRNAs are destabilized more than non-targets matched for their codon optimality 
(Fig 4c), suggesting FMRP binding could lead to enhanced stability in addition to that provided 
by optimal codons. In yeast, the Ccr4-Not complex directly binds the empty E site of the 
ribosome during ineffective decoding on a non-optimal codon, thereby rendering the mRNA 
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more susceptible to degradation (52). One can postulate that the E site on an optimal codon is 
more frequently occupied compared to a non-optimal codon, and therefore is less likely to be 
recognized by the Ccr4-Not complex. Moreover, the N-terminus of Drosophila FMRP was also 
shown to be able to bind directly to ribosomes (53). If these findings are conserved in 
mammalian systems, FMRP binding to ribosomes may further reduce the chance of Ccr4-Not 
binding. 
We cannot rule out the possibility that FMRP may “sense” other features of mRNA, e.g. GC 
content of the coding sequence. In mammalian systems, mRNAs that contain many optimal 
codons inevitably have higher GC content in the coding sequence, which predicts a stronger 
secondary structure (40). Interestingly, mRNAs that have reduced steady state RNA levels or 
have increased degradation rates tend to have long CDS, which also predicts more CDS mRNA 
structures, as suggested by their low MFE (Fig S3). In mammalian cells, strong secondary 
structure in the CDS stabilizes mRNA, possibly by preventing strand-specific endonucleolytic 
cleavage or ribosome collisions (40). FMRP binding may help stabilize such structures in the 
CDS, thereby reducing RNA degradation. Indeed, there is at least in vitro evidence that RNA 
secondary structure is recognized by FMRP (1). On the other hand, DDX6 was shown to 
mediate mRNA decay of GC rich mRNAs, possibly by facilitating unwinding of the secondary 
structures throughout the transcripts and facilitating XRN1 progression (39). Therefore, it is 
possible that FMRP stabilizes the mRNAs by antagonizing DDX6 and XRN1. Indeed, the 
orthologues of the mRNAs downregulated in the mouse FK brain are upregulated upon loss of 
DDX6 and XRN1 in human cells (Fig 4d), suggesting FMRP, DDX6 and XRN1 may share 
common targets. By interacting with DDX6, FMRP could regulate a much wider pool of mRNAs 
than those in the FMRP target list (5).  
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Material and Methods 
Animals 
WT, FK, CK and dKO mice were as used previously (10). Specifically, FK (JAX stock# 004624) 
and its WT controls (JAX stock# 004828) were purchased from the Jackson Lab. CK were 
created in-lab (54). Mice were bred as previously described (10). All mice were maintained in a 
temperature- (25°C), humidity- (50–60%) and light-controlled (12 hr light-dark cycle) and 
pathogen-free environment. Animal protocols (#1158) were approved for use by the University 
of Massachusetts Medical School Institutional Animal Care and Use Committee (IACUC).  
Ribosome profiling and RNA-seq in cortex 
Two mice per genotype were used for ribosome profiling and RNA-seq. The brain was rapidly 
removed from P28–P35 mice, rinsed in ice-cold dissection buffer (1× HBSS + 10 mM HEPES-
KOH), rapidly dissected in dissection buffer ice-liquid mixture to collect cerebral cortex as 
described previously(55). Both cortex hemispheres were homogenized in 900µl of 
homogenization buffer(55) (10 mm HEPES-KOH, pH 7.4, 150 mm KCl, 5 mm MgCl2, 0.5 mm 
DTT, 100 µg/ml cycloheximide and 2 µg/ml harringtonine), containing protease and 
phosphatase inhibitors (cOmplete, EDTA-free Protease Inhibitor Cocktail and PhosSTOP from 
Roche/Sigma, cat. no. 11836170001 and 4906837001), in a pre-chilled 2-mL glass Dounce 
homogenizer, 20 strokes loose, 20 strokes tight, and centrifuged at low speed (2000 rcf 10 min 
4°C) to pellet insoluble material(10). Five hundred microliters of the resulted ~700µl supernatant 
(cytoplasmic lysate) were used for ribosome profiling, the rest for RNA-seq. For ribosome 
profiling, the lysate was digested by 60 U RNase T1 (Thermo Scientific, cat. no. EN0541) and 
100ng RNase A (Ambion, cat. no. AM2270) per A260 unit(56) for 30 min at 25°C with gentle 
mixing. Digestion was stopped by adding 30 µl SUPERase·In (Invitrogen, cat. no. AM2694). 
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Digested lysate was separated by sedimentation through sucrose gradients. Monosome 
fractions were identified, pooled, and extracted with TRIzol LS (Invitrogen, cat. no. 10296028).  
For RNA-seq, cytoplasmic RNA was extracted from the lysate using TRIzol LS. Ten micrograms 
of RNA were depleted of rRNA using Ribo-Zero Gold rRNA Removal Kit, Human/Mouse/Rat 
(Illumina, discontinued), and fragmented by incubating with PNK buffer (NEB, cat. no. M0201S) 
for 10 min at 94°C. Fragmented RNA as separated on 15% urea-polyacrylamide gel, and 50-
60nt fraction was collected.  
Ribosome profiling and RNA-seq libraries were prepared following published protocols(57) and 
sequenced with Illumina NextSeq.  
Spike-in RNA for RNA metabolism profiling 
D. melanogaster (fly) Schneider 2 (S2) cells were grown in 12 ml Schneider’s insect medium 
(Sigma-Aldrich, cat. no. S0146) containing 10% (v/v) of Fetal Bovine Serum (FBS, Sigma-
Aldrich, cat. no. F2442) at 28°C until confluent. Cells were incubated with 200 µM 5-EU for 24 
hr, and were washed, pelleted and snap frozen in liquid nitrogen. RNA was extracted using 
TRIzol.  
S. cerevisiae (yeast) cells were grown in 10 ml YEP medium containing 3% glucose at 30°C 
until OD600 nm reaches 0.5. Cells were then pelleted and RNA was extracted using hot acidic 
phenol (58).  
RNA metabolism profiling with cortical neuron cultures 
Cortical cell suspension were obtained by dissociating cerebral cortices from E18 embryos 
using the Papain Dissociation System (Worthington, cat. no. LK003150). One million live cells 
were plated in 5 ml complete Neurobasal culture medium (Neurobasal™ Medium (Gibco, cat. 
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no. 21103049), 1x B-27 supplement (Gibco, cat. no. 17504044), 1x Antibiotic‐Antimycotic 
(Gibco, cat. no. 15240096), 1x GlutaMAX (Gibco, cat. no. 35050061)) per 60 mm poly-L-lysine 
treated cell culture dish. Neurons were fed by half-replacing the complete Neurobasal culture 
medium twice per week. DIV14 neurons were incubated with 200 µM 5-EU (Click-iT™ Nascent 
RNA Capture Kit, Invitrogen, cat. no.  C10365) for 0 (input and “unlab”), 20 (“A”), and 60 (“B”) 
min. Neurons were then washed with ice cold 1x PBS buffer, and RNA was extracted using 
TRIzol (Invitrogen, cat. no. 15596018). Five-EU labeled RNA was enriched and RNA-seq library 
was prepared by adapting the Forrest et al protocol (59). Specifically, mouse neuron RNA was 
spiked-in with 10% (w/w) 5-EU labeled fly RNA and 10% (w/w) yeast RNA. The mixed RNA was 
depleted of rRNA using the Ribo-Zero Gold rRNA Removal Kit (Human/Mouse/Rat) and 
fragmented using NEBNext® Magnesium RNA Fragmentation Module (NEB, cat. no. E6150S) 
for 5 min. RNA samples for libraries unlab, A and B were biotinylated by Click-iT chemistry and 
pulled-down using the Click-iT™ Nascent RNA Capture Kit. The pulled-down samples, together 
with the input sample, were subjected to library construction the same as for ribosome profiling 
libraries(57). Here, for the pulled-down samples, all reactions were performed directly on beads 
until after the reverse transcription step. Sequencing library fraction with insert size 50-200nt 
was collected and sequenced with Illumina NextSeq. For each WT and FK, two independent 
batches of neurons were prepared, and each batch resulted in one of each input, unlab, A and 
B libraries (Table S4). 
Differential translation and RNA expression analysis 
Brain cortex ribosome profiling and RNA-seq reads were processed as previously described11, 
which includes the following steps: 1) reads were separated based on sample barcode 
sequences; 2) known 3’ adapter sequences and low quality bases were removed with 
Cutadapt(60) using parameters -O 2 -q 15 -a 
“TGGAATTCTCGGGTGCCAAGGAGATCGGAAGAGCGGTTCAGCAGGAATGCCGAGACCG”; 3) reads mapped to rRNA and 
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tRNA genes were removed using Bowtie2(61) with parameter -N 1; 3) remaining reads were 
mapped to the mm10 genome using TopHat2(62); and 4) PCR duplicates were removed based 
on Unique Molecular Identifier sequences. 
Uniquely mapped reads were then used as input to RSEM(63) for quantification of gene 
expression and either mapped to RefSeq (v69) mouse coding sequences (RPF) or to whole-
transcriptome (RNA-seq). Genes were filtered to have a minimum of 10 TPM (transcripts per 
million) in at least one sample. We used log transformed TPM expression values to correct for 
batch effects using ComBat (64) (v3.18.0). Corrected values were transformed back to read 
counts using the expected size of each transcript informed by RSEM. Batch-corrected counts 
were used to identify differentially translated/expressed genes with DESeq2 (65) (RPF and 
RNA) or Xtail (31) (ribosome occupancy, RO). To identify mRNAs with significant DROs, a FDR 
< 0.05 was used as cut off. To identify mRNAs with strongest changes at RPF and RNA levels, 
a padj < 0.1 was used as cut off. 
GO analysis 
GO enrichment analysis was performed using Cytoscape with the ClueGo(66) plug-in (v2.3.3), 
with genes that are expressed in the mouse cortex as the reference gene set. Specifically, 
biological function GO terms of levels 6-13 were tested for enrichment at adjusted p-value < 
0.05 (Right-sided hypergeometric test). Enriched GO terms that are similar were then fused to a 
group based on their Kappa score which quantifies percentage of common genes between 
terms. The leading group terms, which are the terms with highest significance in each group, 
are presented in Fig 1d and Fig S6a. All enriched terms are in Table S1-3.  
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RNA metabolism profiling analysis 
Reads generated from the RNA metabolism profiling libraries were processed as for cortical 
RNA-seq libraries described above, except that a mouse-fly-yeast merged genome (mm10 + 
dm6 + sacCer3) was used as the reference genome for reads mapping by hisat2. The mapping 
statistics here were used for quality control and filtering purposes (Fig S2a-d). Uniquely mapped 
reads that are depleted of rRNA, tRNA sequences and PCR duplicates were again mapped to 
mm10 genome with hisat2. Intron and exon read quantification, and RNA metabolism rates 
(synthesis, processing and degradation) estimation was performed using INSPEcT (37) 
(v1.10.0), with the degDuringPulse parameter set to TRUE. One set of libraries, which was of 
low complexity (Table S4), was still used to confirm the global shift of degradation rates in FK 
neurons. This reproducible global shift allowed us to normalize WT and FK libraries separately 
for our gene level analysis (Fig S2f). Specifically, raw RNA metabolism rates estimated by 
INSPEcT were normalized between libraries A and B for WT and FK neurons separately using 
the limma package(67) with the “cyclicloess” method. After normalization, genes with different 
metabolism rates were tested using the limma package. 
Codon adaptation index (cAI) 
The codon adaptation index was calculated for a given sample as described by Sharp & Li (ref 
1987). Briefly, for each sample, a set of the top 10% expressed genes was defined using batch-
corrected TPM; the relative synonymous codon usage was then calculated, dividing the 
observed frequency of each codon by the frequency expected assuming all synonymous 
codons for a given amino acid are used equally; the codon adaptation index (cAI) is then 
calculated by comparing the frequency of each codon to the frequency of the most abundant (or 
optimal) codon for a given amino acid. All codes used to perform this analysis are available on 
GitHub (https://github.com/elisadonnard/CodonOPT). Codon cAI and gene cAI scores were 
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calculated for both brain cortex and neurons, which are largely identical (data not shown). Only 
neuron cAI’s and gene cAI scores are presented. 
Codon-stability coefficient (CSC) analysis 
CSCs were calculated as previously described (23, 24, 26, 27). Specifically, a Pearson’s 
correlation coefficient was calculated for each of the 60 non-start and -stop codons between the 
frequencies of this codon in all the genes that use this codon, and the stability of these genes. 
The stability of a gene (y), which is the inverse of its degradation rate (x), is expressed as 
follows: 
y   log
 
	


 log
 
	

/2 
Here 	

 and 	

 are the normalized degradation rates from library A and B, respectively. The 
highest expressed isoform of each gene was used to calculate the usage frequencies of each 
codon. 
Minimum free energy (MFE) analysis 
The sequences of 5’UTR, CDS, and 3’UTR were first extracted from the highest expressing 
isoform of each gene using Biostrings (v2.54.0) (68), minimum free energy (MFE) of each 
sequence was then calculated using RNALfold module in ViennaRNA (v2.4.14) (69) with the 
default parameters. 
RNA Immunoprecipitation 
HEK 293T cells (ATCC) were cultured with DMEM media, supplied with 10% FBS and 1% 
Antibiotic Antimycotic Solution (Gibco). Cells of passages between 6 and 9 were transfected 
with lipofectamine 3000 based on manufacture’s instruction in 6-well plate. 48 hr post 
transfection, cells are quickly washed in ice cold PBS buffer and collected in complete 
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homogenization buffer as used for ribosome profiling above, plus 1% NP40. After incubating on 
ice for 10 min, lysate is cleared by centrifuging at 20,000 rcf for 10 min at 4°C. 10% of the lysate 
was collected as input sample, the rest of the lysate is diluted 1:10 with NT2 buffer (50 mM Tris-
HCl (pH 7.4), 150 mM NaCl, 1 mM MgCl2, 0.05% NP40) (70). Each half of diluted lysate is 
incubated with 1/10 volume of antibody coated Protein G Dynabeads™ (Invitrogen) for 40 min 
at 4°C by end to end rotation. The beads have been coated with Monoclonal ANTI-FLAG® M2 
antibody (Sigma-Aldrich) or unimmuned mouse IgG (Santa Cruz). After washing 3 times with 
NT2 buffer, the beads and the input sample are extracted with TRIzol™ Reagent (Invitrogen), 
and RNA is precipitated overnight. cDNA is made with QuantiTect Reverse Transcription Kit 
(Qiagen). qPCR is performed to quantify the reporters (27) with mCherry sequences, and Fmr1 
gene, with primers mCherry-F gtacgggtcaaaagcttacgtt, mCherry-R ccttctggaaatgaaagtttaagg, 
Fmr1-F cgcggtcctggatatacttc, Fmr1-R tggagctaatgaccaatcactg. Recovery rate of the reporters 
and of Fmr1 is calculated as the ratio of immunoprecipitated RNA versus the input RNA. To 
account for differences in immunoprecipitation efficiencies between experiments, normalized 
recovery rate is calculated as the ratio of the recovery rate of the reporter versus the recovery 
rate of Fmr1 in each technical replicate, using the recovery rate of Fmr1 as an internal control. 
Code availability 
All codes used to perform cAI analysis are available on GitHub 
(https://github.com/elisadonnard/CodonOPT). Other customized R scripts for data analysis are 
available from the corresponding authors upon request.  
Data availability 
The data supporting the findings of this study have been deposited in the Gene Expression 
Omnibus (GEO) repository with the accession code GSE140565 and GSE140642. All other 
data are available from the corresponding authors upon reasonable request. 
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Figure legends 
Figure 1: Steady state RNA level changes drive translational buffering in Fragile X brain 
cortex. a, Illustration of the experimental pipeline of ribosome profiling and RNA-seq for WT and 
FMRP-knockout (FK) mouse brain cortices. RPF: ribosome protected fragments. b, heatmaps 
showing log2FC of RPF, RO (ribosome occupancy), and RNA levels for mRNAs having 
statistical significant different ROs as calculated using Xtail (31) between FK and WT (2 
biological replicates for each genotype, FDR < 0.05). c, Venn diagram showing the overlap of 
mRNAs with DRO and mRNAs that are differentially expressed. d, Representative Gene 
Ontology (GO) terms enriched for mRNAs down regulated at the RNA level in the FK brain 
cortex. Grey bars and red point-and-lines show the –log10(P value) and fold enrichments of each 
of these GO terms, respectively. See Table S1 for full lists of enriched GO terms. e, Venn 
diagrams showing the overlap between the downregulated mRNAs and FMRP binding targets 
(5). Numbers of RNAs in each group and in each overlap as well as p-values of enrichment 
(hypergeometric test, upper tail) are indicated. f, ECDF plots showing log2FC of RPF, RO, and 
RNA levels for FMRP binding targets (5) and other mRNAs.  
Figure 2: Increased mRNA degradation rates in FK neurons correlate with the steady 
state RNA depletion. a, Illustration of the experimental pipeline of RNA metabolism profiling for 
WT and FK neurons. Unlab./lab.: unlabeled/labeled. tL: time labeled. b, Heatmap of Spearman’s 
correlation coefficients between synthesis (syn.), processing (pro.), and degradation (deg.) rates 
estimated from RNA-seq libraries generated from WT and FK neurons labeled for 20 (A) or 60 
(B) minutes. Dendrogram shows the unsupervised hierarchical clustering using their 
Spearman’s correlation coefficients. c-e, ECDF plots of normalized degradation rates for 
downregulated mRNAs in FK cortex (c), FMRP binding targets (d), and mRNAs with DROs (e) 
and other mRNAs, compared between the mRNA groups (left), or between the genotypes 
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(right). The mean of the normalized degradation rates from libraries A and B of each mRNA was 
used. Black vertical lines denote the median degradation rates for all mRNAs. f, Violin-and-line 
plot for the degradation rates of all mRNAs. The mean of the normalized degradation rates from 
libraries A and B of each mRNA was used. The black horizontal line in each violin denotes the 
median. Thin lines span WT and FK connect the values of the same mRNA in both genotypes. 
Brown-grey-green shades of the thin lines indicate the log2FC of the normalized degradation 
rates of each mRNA. g, ECDF plots showing log2FC of RPF, RO, and RNA levels in FK cortex 
compared to WT for mRNAs with faster (brown) or slower (green) degradation rates. 
Figure 3: Increased mRNA degradation rates in FK neurons are codon optimality 
dependent. a, , All mRNAs were grouped into 10 equal bins based on their gene cAI scores. 
Bin 1 contains genes with gene cAI scores of the lowest quantile and bin 10 contains genes of 
the highest quantile. Violin plots show log2FC of degradation rates in FK vs WT neurons for 
mRNAs in each gene cAI score bins. The point in each violin denotes the median of the bin. 
Brown stars indicate the median of the bin greater than 0 (Holm adjusted p-value < 0.01, one 
tailed-t test). No bin had median less than 0. b, ECDF plots of gene cAI scores for mRNAs with 
faster or slower degradation rates in FK neurons (left) or reduced mRNA levels in FK cortex 
(right). c, Bar graphs for Codon-Stability Coefficients (CSC) for each codon as arranged from 
minimum to maximum in WT (upper) and FK (lower) neurons. The color of each bar indicates 
the codon as stabilizing (CSC > 0, green) or destabilizing (CSC < 0, orange) in WT neurons. 
The amino acid for each codon is indicated. d, Scatter plots and linear regressions of the CSCs 
as a function of log10(codon usage frequency) of the top 10% of expressed genes in WT (upper) 
and FK (lower) neurons. Spearman’s rank correlation coefficients and p-values of the 
correlations are indicated. 
Figure 4: FMRP and other factors may regulate optimal codon dependent mRNA stability. 
a, Bar graph of count of FMRP target genes in each gene cAI score bin. b, RNA 
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immunoprecipitation (RIP) testing FMRP recruitment to reporter mRNAs that use optimal versus 
nonoptimal codons. The reporter that uses nonoptimal codons was generated using 1nt 
insertion into the reporter that uses optimal codon (left) (27). Normalized recovery rate was 
calculated by normalizing the recovery rate of the reporter by the recovery rate of the Fmr1 
mRNA, the latter as an internal control for the RIP experiment. Each point, a biological replicate, 
is an average of 2-3 technical replicates. Each line connects data from the two reporters in a 
paired experiment that was performed independently from other pairs. p-value = 0.0261, one-
tailed paired t test. c, Violin plots show log2FC of steady state RNA levels in FK vs WT cortex 
for all FMRP targets (purple) or non-targets (grey) in each gene cAI score bins. The point in 
each violin denotes the median of the bin. d, ECDF plots showing log2FC of RNA levels for 
FMRP binding targets (left) and mRNAs downregulated in FK cortex (right) after knock-down of 
YHDF2 (42), XRN1, and DDX6 (43) in human cell lines. Only genes with unique mouse 
orthologs were considered. e, model of how FMRP could stabilize mRNAs that use optimal 
codons directly and through other factors.  
Figure 5: Genetic rescue of FX by CPEB KO is rebalanced at RNA level. a, illustration of the 
genetic rescue paradigm described previously (10). CK, CPEB1 KO; dKO, double KO. b-c, 
Heatmaps showing mRNAs having differential RO (b) and RPF (c) between any two genotypes 
of the four genotypes noted above. d, Heatmaps showing mRNAs that are differentially 
expressed between the normal (WT and dKO) and FXS-like groups (FK and CK). Red and blue 
shades of the heatmaps show high or low z-scores calculated for each mRNA (row) across all 
samples. Each genotype has 2 biological replicates.  
Figure S1: RNA levels changes in Fragile X mouse and human models. a, ECDF (empirical 
cumulative distribution function) plots showing log2FC of RPF, RO (ribosome occupancy), and 
RNA levels for mRNAs having statistical significant different ROs as calculated using Xtail (31) 
between FK and WT (2 biological replicates for each genotype, FDR < 0.05). Numbers show the 
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means of each group. b, ECDF (empirical cumulative distribution function) plots for 
log2FoldChange in published RNA-seq data sets of various FXS models (20, 47, 48, 71) for 
FMRP binding targets (5) (purple; left) and mRNAs downregulated in FK brain cortex in current 
study (blue, right). The animal species and tissue/cell typed used in each of these studies is 
indicated. P-values were calculated for the log2FoldChange values of the FMRP targets (purple) 
and of the downregulated mRNAs identified in this study (blue) to be smaller than 0 (Wilcoxon 
test, lower tail). For data from Thomson et al. (48), genes were filtered for normalized counts 
between 102.5 and 104.25 as was done in the original publication. For data generated using 
human embryonic stem cells (71), only genes with unique mouse orthologs were considered.  
Figure S2: RNA metabolic profiling in WT and FK neurons. a, Bar graph of fractions of 
reads uniquely mapped to mouse (orange) or fly (Drosophila) (green) transcriptome in each 
library. As expected, the pulled-down libraries (A, B and unlab) were enriched in reads mapped 
to the fly transcriptome (5-EU labeled to saturation) over that of mouse (5-EU labeled only for a 
brief pulse). The input libraries were not subjected to pull-down and had more reads mapped to 
mouse compared to fly. Unlab libraries had the smallest ratio of reads that mapped to mouse, 
demonstrating minimum background to the pull-down process. Accordingly, libraries from 
mouse neurons that are labeled for a shorter time (20min, libraries A) had smaller ratios of 
reads mapped to mouse transcriptome than that labeled for longer (60min, libraries B). b, Bar 
graph of ratio of reads that uniquely mapped to Drosophila transcriptome vs that to yeast in 
each library. Ratios are scaled so that the mean of this ratio in WT input and in FK input libraries 
is 1. Similar to panel a, the high Drosophila to yeast ratio demonstrates specific pull-down to 
enrich for 5-EU labeled RNA. c, Bar graph of fractions of reads that uniquely mapped to exons 
(orange) and introns (green) among those uniquely mapped to the mouse transcriptome. As 
expected, input libraries are composed mostly of mature mRNAs and therefore had 
predominantly exon reads. Similarly, the exon/intron ratio for unlab libraries represents 
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nonspecific signal that originates from the input RNA pool. Libraries from mouse neuron RNAs 
that are labeled for short (20min, A) or longer (60min, B) are mostly composed of nascent 
transcripts and therefore had more introns. Accordingly libraries labeled for a shorter time (A) 
had more introns than that labeled for longer (B). d, Density plots of RPKM (read per kb per 
million reads uniquely mapped to mouse-fly-yeast combined genome) of each mouse gene in 
input (orange) and unlab (green) libraries in WT (left) and FK (right) neurons. Filtering 
thresholds (black vertical lines) were identified for WT and FK at 0.95 and 1.05 RPKM, 
respectively. Genes were filtered for those that had RPKM higher than threshold in input (i.e., 
that are expressed) and lower than threshold in unlab libraries (i.e., that do not have high 
nonspecific pull-down background). Data of genes that survive filtering in both WT and FK 
libraries are analyzed by the INSPEcT program (37) to estimate RNA metabolism rates. e, Violin 
plots for synthesis, processing and degradation rates estimated for libraries A and B. Each violin 
contains data from both WT and FK. Black horizontal lines denote median of each violin. Grey 
horizontal lines denote the median of both violins. f, Pipeline for normalization and statistical 
tests for genes with differential RNA metabolic rates, using the degradation rate as the example 
that is shown. We observed reproducible global faster degradation rates in FK than WT in both 
libraries A and B and in both data set 1 (high quality libraries, presented in this study) and data 
set 2 (independent data set, low complexity lacks statistical power and was rejected for gene-
level analysis (gray shaded graphs) but was sufficient for confirming global-level shift) (left; 
Table S4). To capture the global shift between genotypes while testing for genes with 
significantly different metabolism (i.e., synthesis, processing, and degradation) rates, we 
considered library A and B in data set 1 as pseudo-replicates and normalized them using the 
Limma package (67) for each genotype separately. With normalized RNA metabolic rates, 
genes with significantly different rates between genotypes were then called (right). g, Venn 
diagrams showing overlaps between mRNAs with faster (brown) or slower (green) degradation 
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rates and FMRP CLIP targets (left, pink). Numbers of mRNAs in each group and each overlap, 
as well as the p-value of enrichment of each overlap, are indicated. 
Figure S3: RNA changes and codon optimality. a, Scatter and 2D density contour plots of 
log2FC of steady state RNA levels in FK cortex versus WT (left) and that of degradation rate in 
FK neurons versus WT (right) as a function of a series of features of the transcripts as indicated. 
The highest expressed isoform of each gene was used. The red straight line shows the linear 
regression of the data points. Pearson's product−moment correlation coefficients are indicated. 
b, Scatter plots comparing CSC (codon stability coefficient) of all non-start or -stop codons in 
WT neurons in this study (y axis) and that in several mouse and human cell lines shown by Wu 
et al (27). CSCs in mouse ESC were calculated by Wu et al. based on data published by 
Herzog et al (72). CSCs in human cells lines (293T, HeLa, and RPE) measured by either 
blocking transcription (“endo”) or SLAM-seq (“SLAM”) were generated by Wu et al (27). 
Figure S4: Additional protein factors that may participate in FMRP regulated optimal 
codon dependent mRNA stability. a, EDCF plot showing log2FC of degradation rate change 
in FK neurons versus WT for FMRP binding targets and non-targets. b, ECDF plots showing 
log2FC of RNA levels for FMRP binding targets (purple) and mRNAs downregulated in FK 
cortex (blue) after depletion of FXR1 (45), SMG6 (73), PCBP2 (74), U2SURP and CHERP (75). 
For the dataset generated using human cell lines (45, 75), only genes with unique mouse 
orthologs were considered. 
Figure S5: RNA levels changes among the four genotypes of the FXS rescue paradigm. a, 
Heatmap showing differentially expressed mRNAs between any two genotypes of the four 
genotypes (WT, FK, CK, and dKO). Red and blues shades show high or low z-scores for each 
mRNA (row) across all samples. Both replicates are plotted separately for each genotype. b, 
Unsupervised hierarchical clustering of sample to sample distances measured by the Euclidean 
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distance between each other using their top 1000 most variable mRNAs. Darker to lighter 
shades of blue indicate closer to farther distance between samples. Dendrogram represents the 
clustering. 
Figure S6: Additional information about the mRNAs differentially expressed between the 
normal (WT and dKO) and the FX-like (FK and CK) groups. a, Representative Gene 
Ontology (GO) terms enriched for genes upregulated (upper) or down regulated (lower) at the 
RNA level in the FXS-like group. Grey bars and red point-and-lines show the –log10(P value) 
and fold enrichment of each of these GO terms, respectively. See Table S2-3 for full lists of 
enriched GO terms. b, Density plot of the distribution of mRNAs up- (red) or down- (blue) 
regulated in the FXS-like group over RNA transcript per million (TPM) bins. Bins were generated 
by dividing all detectable protein coding genes into 10 equal bins based on their TPM in WT 
brain. Bin 1 genes have TMPs of the lowest quantile and bin 10 the highest quantile. c, Venn 
diagram showing the overlap between the differentially expressed mRNA with all SFARI autism 
risk genes (51). Numbers of mRNAs in each group and in each overlap as well as p-values of 
enrichment (hypergeometric test, upper tail) are indicated. 
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